BIOS - Merger Agreement and Earnings Review in this Comprehensive Report on BioScrip
NEW YORK, NY / ACCESSWIRE / March 18, 2019 / Traders News Source, a leading independent equity researchand corporate access firm focused on small and mid-cap public companies isissuing a comprehensive report on BioScrip Inc. (NASDAQ: BIOS), a provider of infusion and home care management solutions, with approximately 2,500 teammates and nearly 80 service locations across the U.S. BioScrip partners with physicians, hospital systems, pharmaceutical manufacturers and skilled nursing facilities to provide patients access to post-acute care services.
Recently, BioScrip and Option Care jointly announced a definitive merger agreement, which will create the nation's preeminent home infusion company and transform the industry. The combined company will have a national footprint of more than 150 locations in 46 states.
About the merger agreement, recent earnings review and more here READ MORE
Copy and paste to your browser may be required to view the report - https://tradersnewssource.com/bioscrip-2/
On Friday, BIOS traded 15 million shares with a high of $3.77 and a low of $2.33 before settling at $2.78 per share.
Option Care's signature Home Infusion Plus services include the clinical management of infusion medicines, nursing support, and care coordination. Option Care's multidisciplinary team of more than 1,800 clinicians - including pharmacists, nurses, and dietitians - are able to provide home infusion service coverage for nearly all patients across the United States needing treatment for complex and chronic conditions.
Complimentary report, infusion market, more about Option Care and potential synergies READ MORE
Copy and paste to your browser may be required to view the report - https://tradersnewssource.com/bioscrip-2/
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://www.tradersnewssource.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
CONTACT: editor@tradersnewssource.com
SOURCE: Traders News Source